DG3173 (somatoprim), a unique somatostatin receptor subtypes 2-, 4- and 5-selective analogue, effectively reduces GH secretion in human GH-secreting pituitary adenomas even in Octreotide non-responsive tumours (Q60727879)
Jump to navigation
Jump to search
scientific article published on 07 November 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | DG3173 (somatoprim), a unique somatostatin receptor subtypes 2-, 4- and 5-selective analogue, effectively reduces GH secretion in human GH-secreting pituitary adenomas even in Octreotide non-responsive tumours |
scientific article published on 07 November 2011 |
Statements
DG3173 (somatoprim), a unique somatostatin receptor subtypes 2-, 4- and 5-selective analogue, effectively reduces GH secretion in human GH-secreting pituitary adenomas even in Octreotide non-responsive tumours (English)
U Plöckinger
U Hoffmann
M Geese
A Lupp
M Buchfelder
J Flitsch
P Vajkoczy
W Jakob
W Saeger
7 November 2011